Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03303248 · ClinicalTrials.gov registry record · NA
Evaluation of Web-based Transition Education to Enhance Transition Readiness
A NA study of Congenital Heart Disease and Pediatric Congenital Heart Disease, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT03303248: Completed NA study of Congenital Heart Disease and Pediatric Congenital Heart Disease, sponsored by University of Michigan.
NCT03303248 is a NA study of Congenital Heart Disease and Pediatric Congenital Heart Disease that has completed, run by University of Michigan. The registered enrollment target is 180 participants, below the 471-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03303248, a NA study of Congenital Heart Disease and Pediatric Congenital Heart Disease, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The study looks to learn more about the helpfulness of web-based transition education and its effect on transition readiness and health service utilization in the adolescent and young adult congenital heart disease population.
Primary Outcome
The transition readiness survey is used to measure a participant's self-reported knowledge about their health and readiness to take charge of their healthcare. Each item is scored from 1 to 5, where 1 means "No, I do not know how" and 5 means "Yes, I always do this when I need to." The overall score is determined by calculating the sum of all questions on a 100 point scale. A higher score indicates greater readiness for transition.
Conditions Studied
Interventions
- BEHAVIORAL Web-based Educational Intervention
Study Locations (1)
Michigan
- C.S. Mott Children's Hospital - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What the finished NCT03303248 record still lists
NCT03303248 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 471-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (62% lower).
The record links to 3 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Web-based Educational Intervention is the first listed.
NCT03303248 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03303248 about?
NCT03303248 is a clinical study titled "Evaluation of Web-based Transition Education to Enhance Transition Readiness". The study looks to learn more about the helpfulness of web-based transition education and its effect on transition readiness and health service utilization in the adolescent and young adult congenital heart disease population.
What is the current status of trial NCT03303248?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2018-08-27. Estimated completion is 2025-06-30.
What conditions does trial NCT03303248 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Pediatric Congenital Heart Disease, Transition.
What interventions are being tested in trial NCT03303248?
The interventions under investigation include: Web-based Educational Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03303248?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03303248 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03303248's enrollment target sits among peer trials
180 23rd of 63 higher than 41 of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
-
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
RECRUITING · NA
-
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
RECRUITING · NA
-
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI